GIGVHD
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease (NCT02245412) | Alexion Pharmaceuticals, Inc. | 2014-11-14 |
Track GIGVHD automatically
Every clearance here is in the API, with alerts when new ones post.